The global fetal monitoring market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, at a CAGR of 7.3% during the forecast period. Growth in this market is mainly driven by the rising prevalence of preterm births, favorable government policies, and active product launches by key players in the market.

Request for Free Sample Report

Key Findings of the Report

• The ultrasound devices segment accounted for the largest share of the fetal monitoring market in 2021, and is expected to continue to dominate the market during the forecast period.
• The non-portable systems segment accounted for the largest share of the fetal monitoring market in 2021, and is expected to continue to dominate the market during the forecast period.
• The non-invasive segment accounted for the largest share of the fetal monitoring market in 2021, and is expected to continue to dominate the market during the forecast period.
• The antepartum segment accounted for the largest share of the fetal monitoring market in 2021, and is expected to continue to dominate the market during the forecast period.
• The hospitals segment accounted for the largest share of the fetal monitoring market in 2021, and is expected to continue to dominate the market during the forecast period.
• North America was the largest regional market for fetal monitoring in 2021, and is expected to continue to dominate the market during the forecast period.

Drivers of the Market

• The rising prevalence of preterm births is a major driver of the fetal monitoring market. Preterm birth is defined as a birth that occurs before 37 weeks of gestation. The World Health Organization (WHO) estimates that approximately 15 million preterm births occur each year, and that preterm birth is the leading cause of neonatal mortality.
• Favorable government policies are also driving the growth of the fetal monitoring market. In many countries, governments are providing financial incentives for the use of fetal monitoring devices. For example, in the United States, the Centers for Medicare and Medicaid Services (CMS) reimburses for the use of fetal monitoring devices.
• Active product launches by key players in the market are also driving the growth of the fetal monitoring market. In recent years, key players have launched a number of new fetal monitoring devices, including ultrasound devices, electronic maternal/fetal monitors, and uterine contraction monitors.

Restraints of the Market

• The high cost of fetal monitoring devices is a major restraint on the growth of the market. Fetal monitoring devices can be expensive, and this can make them unaffordable for some patients.
• The lack of skilled healthcare professionals is another restraint on the growth of the market. In many countries, there is a shortage of healthcare professionals who are trained to use fetal monitoring devices. This can make it difficult for patients to access fetal monitoring services.

Opportunities in the Market

• The development of non-invasive, portable, and advanced fetal monitors is an opportunity for the fetal monitoring market. Non-invasive fetal monitors are less invasive than traditional fetal monitors, and they are easier to use. Portable fetal monitors can be used in a variety of settings, including home settings. Advanced fetal monitors provide more information about the fetus, and they can help to improve the diagnosis and management of fetal conditions.
• The growth of the Asia Pacific market is an opportunity for the fetal monitoring market. The Asia Pacific region is home to a large and growing population, and the region is experiencing a rise in the number of preterm births. This is creating a demand for fetal monitoring devices in the region.

Key Players in the Market

• GE Healthcare (US)
• Siemens Healthineers (Germany)
• Koninklijke Philips N.V. (Netherlands)
• FUJIFILM SonoSite, Inc. (US)
• Cardinal Health, Inc. (US)

Request for Free Sample Report

The global fetal monitoring market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, at a CAGR of 7.3% during the forecast period. Growth in this market is mainly driven by the rising prevalence of preterm births, favorable government policies, and active product launches by key players in the market.